Nanotechnology developed at Rutgers University-New Brunswick could boost research on stem cell transplantation, which may help people with Alzheimer's disease, Parkinson's disease, other neurodegenerative diseases and central nervous system injuries.
Research from the University of Cincinnati finds that among women who are kidney transplant recipients, Hispanic women have a higher likelihood of pregnancy than white women.
As a medical emergency caused by severe cardiovascular diseases, myocardial infarction (MI) can inflict permanent and life-threatening damage to the heart. A joint research team comprising scientists from City University of Hong Kong (CityU) has recently developed a multipronged approach for concurrently rejuvenating both the muscle cells and vascular systems of the heart by utilizing two types of stem cells. The findings give hope to develop a new treatment for repairing MI heart, as an alternative to heart transplant.
A new study from the University of Eastern Finland shows that the health-related quality of life of most people who have or have a higher risk of knee osteoarthritis remained unchanged over an eight-year trajectory. Worsening of quality of life was associated with several risk factors, such as obesity and smoking, and it also reflected the patient's need for treatment.
Mount Sinai researchers have developed a way to use immunotherapy drugs against treatment-resistant non-Hodgkin's lymphomas for the first time by combining them with stem cell transplantation, an approach that also dramatically increased the success of the drugs in melanoma and lung cancer, according to a study published in Cancer Discovery in July.
Several countries have combated low organ donor counts by implementing a priority rule that pushes registered donors to the front of the line if they ever need a transplant. However, according to a study from the McCombs School of Business at The University of Texas at Austin published today in Management Science, this model has drawbacks.
Scientists are a major step closer to 3D bioprintng functional organs, after team of Carnegie Mellon University researchers devise a method of rebuilding components of the human heart, according to a study published in Science. The team developed an advanced version of Freeform Reversible Embedding of Suspended Hydrogels (FRESH) technology, licensed to FluidForm, to 3D print collagen with unprecedented complexity and construct components of the heart, from small blood vessels to valves to beating ventricles.
A group of European scientists led by KU Leuven has found a biomarker that can identify patients with symptoms of kidney rejection symptoms after a transplant as a result of antibodies. The identification can be done through a simple blood test and at an early stage. It is the first known biomarker for rejection by antibodies. The researchers hope that the test can be further developed quickly for use in the hospital.
Cell freezing (cryopreservation) -- which is essential in cell transfusions as well as basic biomedical research -- can be dramatically improved using a new polymeric cryoprotectant, discovered at the University of Warwick, which reduces the amount of 'anti-freeze' needed to protect cells.
A UCLA-led research team has found that giving mice antibiotics for 10 days prior to a liver transplant leads to better liver function after the surgery. They they found data from previously transplanted patients finding that it works in humans. It's all linked to the gut microbiome.